Marcela Peña-Rodríguez

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Alcohol Use Disorder

Gas Chromatography Mass Spectrometry

Metabolic Syndrome

Top Venues

Journal of applied microbiology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Tonatiuh Abimael Baltazar-Díaz, Luz Alicia González-Hernández, Juan Manuel Aldana-Ledesma, Marcela Peña-Rodríguez, Alejandra Natali Vega-Magaña, Adelaida Sara Minia Zepeda-Morales, Rocío Ivette López-Roa, Susana Del Toro-Arreola, Martínez-López Erika, Adriana María Salazar-Montes, Miriam Ruth Bueno-Topete
Escherichia / Shigella , SCFAs, and Metabolic Pathways-The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic Cirrhosis from Western Mexico. Microorganisms 10 (6) (2022)
Fernando Amador-Lara, Jaime Federico Andrade-Villanueva, Alejandra Natali Vega-Magaña, Marcela Peña-Rodríguez, Monserrat Alvarez-Zavala, Karina Sánchez-Reyes, Marcela Toscano-Piña, Alejandro Aarón Peregrina-Lucano, Susana Del Toro-Arreola, Luz Alicia González-Hernández, Miriam R Bueno-Topete
Gut microbiota from Mexican patients with metabolic syndrome and HIV infection: An inflammatory profile. Journal of applied microbiology 132 (5) (2022)
Jennifer T Wolstenholme, Justin M Saunders, Maren Smith, Jason D Kang, Phillip B Hylemon, Javier González-Maeso, Andrew Fagan, Derrick Zhao, Masoumeh Sikaroodi, Jeremy Herzog, Amirhossein Shamsaddini, Marcela Peña-Rodríguez, Lianyong Su, Yun-Ling Tai, Jing Zheng, Po-Cheng Cheng, R Balfour Sartor, Patrick M Gillevet, Huiping Zhou, Jasmohan Singh Bajaj
Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice. Nature communications 13 (1) (2022)
Alejandra Natali Vega-Magaña, José Francisco Munoz-Valle, Marcela Peña-Rodríguez, Oliver Viera-Segura, Ana Laura Pereira-Suárez, Jorge Hernández-Bello, Mariel García-Chagollan
Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naïve and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2. Vaccines 10 (7) (2022)